Display options
Share it on

Nat Commun. 2016 Sep 27;7:12756. doi: 10.1038/ncomms12756.

Protein kinase D regulates positive selection of CD4.

Nature communications

Eri Ishikawa, Hidetaka Kosako, Tomoharu Yasuda, Masaki Ohmuraya, Kimi Araki, Tomohiro Kurosaki, Takashi Saito, Sho Yamasaki

Affiliations

  1. Division of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi Higashiku, Fukuoka 812-8582, Japan.
  2. Division of Cell Signaling, Fujii Memorial Institute of Medical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
  3. Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
  4. Institute of Resource Development and Analysis, Kumamoto University, 2-2-1, Honjo, Chuo-ku, Kumamoto 860-0811, Japan.
  5. Laboratory for Lymphocyte Differentiation, WPI Immunology Frontier Research Center (iFReC), Osaka University, 3-1 Yamadaoka, Suita 565-0871, Japan.
  6. Laboratory for Cell Signaling, RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
  7. Laboratory for Cell Signaling, WPI Immunology Frontier Research Center (iFReC), Osaka University, 3-1 Yamadaoka, Suita 565-0871, Japan.

PMID: 27670070 PMCID: PMC5052653 DOI: 10.1038/ncomms12756

Abstract

Thymic selection shapes an appropriate T cell antigen receptor (TCR) repertoire during T cell development. Here, we show that a serine/threonine kinase, protein kinase D (PKD), is crucial for thymocyte positive selection. In T cell-specific PKD-deficient (PKD2/PKD3 double-deficient) mice, the generation of CD4 single positive thymocytes is abrogated. This defect is likely caused by attenuated TCR signalling during positive selection and incomplete CD4 lineage specification in PKD-deficient thymocytes; however, TCR-proximal tyrosine phosphorylation is not affected. PKD is activated in CD4

References

  1. Nat Immunol. 2008 Oct;9(10):1122-30 - PubMed
  2. Annu Rev Immunol. 1994;12:555-92 - PubMed
  3. J Exp Med. 2011 Jun 6;208(6):1279-89 - PubMed
  4. Nat Immunol. 2004 May;5(5):539-45 - PubMed
  5. J Exp Med. 2005 Mar 7;201(5):793-804 - PubMed
  6. Immunol Rev. 2009 Mar;228(1):342-59 - PubMed
  7. Nat Immunol. 2008 Oct;9(10):1113-21 - PubMed
  8. Sci Signal. 2010 Dec 21;3(153):ra91 - PubMed
  9. Cell. 2002 Nov 27;111(5):621-33 - PubMed
  10. Nat Rev Immunol. 2002 May;2(5):309-22 - PubMed
  11. Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19979-84 - PubMed
  12. Immunity. 1997 Apr;6(4):389-99 - PubMed
  13. J Immunol. 2000 Nov 15;165(10):5686-94 - PubMed
  14. Nat Immunol. 2004 Mar;5(3):280-8 - PubMed
  15. Int Immunol. 2006 Dec;18(12):1737-47 - PubMed
  16. J Immunol. 1997 Feb 15;158(4):1634-40 - PubMed
  17. EMBO J. 2011 May 18;30(10):2083-93 - PubMed
  18. EMBO J. 1995 Oct 2;14(19):4641-53 - PubMed
  19. Trends Immunol. 2014 Jul;35(7):311-8 - PubMed
  20. Mol Cell Proteomics. 2014 Dec;13(12):3544-57 - PubMed
  21. J Immunol. 2001 Dec 1;167(11):6270-8 - PubMed
  22. Immunity. 1994 Aug;1(5):385-91 - PubMed
  23. Int Immunol. 1999 Dec;11(12):1999-2014 - PubMed
  24. Annu Rev Immunol. 2007;25:473-523 - PubMed
  25. J Biol Chem. 2005 Apr 15;280(15):15013-9 - PubMed
  26. J Immunol. 2007 Jul 1;179(1):483-90 - PubMed
  27. Immunol Lett. 2010 Aug 16;132(1-2):6-11 - PubMed
  28. J Exp Med. 1998 Dec 21;188(12):2301-11 - PubMed
  29. J Leukoc Biol. 2007 Sep;82(3):742-51 - PubMed
  30. Immunity. 1997 Jul;7(1):155-62 - PubMed
  31. Immunol Rev. 2009 Mar;228(1):241-52 - PubMed
  32. Science. 2001 Mar 9;291(5510):1987-91 - PubMed
  33. PLoS One. 2007 Oct 03;2(10):e992 - PubMed
  34. Nat Rev Immunol. 2008 Oct;8(10):788-801 - PubMed
  35. Nat Rev Immunol. 2013 Apr;13(4):257-69 - PubMed
  36. Cell. 1992 Oct 30;71(3):423-35 - PubMed
  37. EMBO Rep. 2011 Jul 08;12(8):785-96 - PubMed
  38. PLoS One. 2013;8(3):e60217 - PubMed
  39. Nature. 2003 Nov 27;426(6965):454-60 - PubMed
  40. J Leukoc Biol. 1993 Nov;54(5):495-503 - PubMed
  41. Nat Immunol. 2003 Mar;4(3):248-54 - PubMed
  42. Immunity. 2003 Oct;19(4):491-501 - PubMed
  43. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12105-10 - PubMed
  44. J Immunol. 2010 Dec 15;185(12):7518-26 - PubMed
  45. Biochem J. 2010 Nov 15;432(1):153-63 - PubMed
  46. J Exp Med. 2000 Jun 19;191(12):2075-82 - PubMed
  47. Nature. 2006 Dec 7;444(7120):724-9 - PubMed
  48. J Biol Chem. 2005 Apr 8;280(14):13205-8 - PubMed
  49. J Biol Chem. 1997 Jan 10;272(2):952-60 - PubMed
  50. Nature. 2005 Feb 24;433(7028):826-33 - PubMed
  51. Proc Natl Acad Sci U S A. 2011 May 31;108(22):9026-31 - PubMed
  52. Nature. 2013 Dec 19;504(7480):441-5 - PubMed
  53. Sci Signal. 2016 May 17;9(428):ra51 - PubMed
  54. Nat Struct Mol Biol. 2009 Oct;16(10):1026-35 - PubMed
  55. Immunity. 1997 Mar;6(3):245-55 - PubMed
  56. EMBO J. 1990 Dec;9(12):3821-9 - PubMed
  57. Nat Immunol. 2010 Mar;11(3):257-64 - PubMed
  58. J Immunol. 2011 Apr 15;186(8):4782-93 - PubMed
  59. J Exp Med. 2013 Jul 1;210(7):1419-31 - PubMed
  60. Sci Signal. 2011 Dec 06;4(202):ra84 - PubMed

Publication Types